[Federal Register Volume 66, Number 141 (Monday, July 23, 2001)]
[Proposed Rules]
[Page 38226]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-18343]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR 864

[Docket No. 95P-0315]


Hematology and Pathology Devices; Reclassification of Automated 
Differential Cell Counters; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Proposed rule; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a 
proposed rule that appeared in the Federal Register of May 9, 2001 (66 
FR 23634). The document proposes to reclassify from class III 
(premarket approval) to class II (special controls) the automated 
differential cell counter (ADCC). The document published inadvertently 
with the incorrect docket number. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy, 
Planning, and Legislation (HF-27), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-7010.

SUPPLEMENTARY INFORMATION: In FR Doc. 01-11580, appearing in the 
Federal Register of Wednesday, May 9, 2001, the following correction is 
made: On page 23634, in the second column, ``[Docket No. 95P-0351]'' is 
corrected to read ``[Docket No. 95P-0315].''

    Dated: July 17, 2001.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 01-18343 Filed 7-20-01; 8:45 am]
BILLING CODE 4160-01-S